Universitätsklinikum Hamburg-Eppendorf: Multiple Sclerosis trials
The registry lists 13 Multiple Sclerosis studies with Universitätsklinikum Hamburg-Eppendorf as lead sponsor. 1 are open to participants now and 1 have results posted.
Phase 1 1Phase 2 3No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Patient Experiences of Multiple Sclerosis (PExMS)Not yet recruitingNCT04236544Not applicable
- Establish Tolerance In MS With Peptide-Coupled, Peripheral Blood Mononuclear CellsCompletedNCT01414634Phase 1/2Results posted
- Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled TrialTerminatedNCT04971005Phase 2
- Intermittent Hypoxia Intervention in MS PatientsCompletedNCT04635033
- Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple SclerosisCompletedNCT04233970Not applicable
- Interactive Web Platform for EmPOWERment in Early Multiple SclerosisCompletedNCT03968172Not applicable
- Understanding Magnetic Resonance Imaging in Multiple SclerosisCompletedNCT03872583Not applicable
- Vision Assessment With the Quick Contrast Sensitivity Function (qCSF) Method in Healthy Controls and MSStatus unknownNCT03703180
- Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple SclerosisStatus unknownNCT03216915
- Armergometry to Improve Mobility in MSStatus unknownNCT03147105Not applicable
- Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MSStatus unknownNCT03114293Not applicable
- Exercise in Multiple Sclerosis: Effects on Cognitive Function and Brain ConnectivityCompletedNCT02005237Not applicable
- Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)CompletedNCT01450124Phase 2